| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |